PA
GEHC icon

PharVision Advisers’s GE HealthCare GEHC Stock Holding History

PharVision Advisers’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,646
Closed -$214K – 334
2025
Q1 		$214K Sell
2,646
-928
-26% -$79.8K 0.3% 185
2024
Q4 		$279K Buy
+3,574
New +$304K 0.24% 179

Other funds holding GEHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PharVision Advisers's GEHC Position: Q2 2025 in Review

PharVision Advisers sold out of GE HealthCare (GEHC) in Q2 2025, closing a stake of 2,646 shares — an estimated $214K sold.

PharVision Advisers first reported a position in GEHC in Q4 2024 and held it in 2 quarters. The position peaked at $279K in Q4 2024. 1,316 funds tracked by Wall St. Rank hold GEHC as of Q2 2025.

  • PharVision Advisers reported no remaining GE HealthCare position as of Q2 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,646 GE HealthCare shares in Q2 2025, an estimated $214K.
  • PharVision Advisers first reported a position in GE HealthCare in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's GE HealthCare position peaked at $279K in Q4 2024.
  • 1,316 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.